Clinical Trials Browser

Phase 2 × NIH × Didanosine × Clear all

NCT00001114 2021-11-01

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

Phase 2 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

NCT00002905 2013-09-20

Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Phase 2 Unknown

Lymphoma